Recce Pharmaceuticals Ltd (RECEF)
OTCMKTS · Delayed Price · Currency is USD
0.2200
-0.2800 (-56.00%)
At close: Jun 24, 2025
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of $121.02 million as of February 12, 2026. Its market cap has increased by 82.01% in one year.
Market Cap
121.02M
Enterprise Value
121.08M
Revenue
4.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 14.13M to 121.02M, an increase of 756.78%. That is a compound annual growth rate of 23.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 121.02M | -3.47% |
| Dec 31, 2025 | 125.38M | 80.16% |
| Dec 31, 2024 | 69.59M | -6.32% |
| Dec 29, 2023 | 74.29M | -7.00% |
| Dec 30, 2022 | 79.88M | -38.62% |
| Dec 31, 2021 | 130.15M | -7.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |